News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Johnson & Johnson Shuts Australian Facility Amid Squeeze On Drug Markets
August 29, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Health-care giant Johnson & Johnson (JNJ) is shutting a biotechnology research facility outside Sydney as part of a cost-cutting effort spurred on by challenging conditions in pharmaceutical markets.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Asia
Australia
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Weight loss
Approvals in Hand, Lilly and Novo Obesity Pills Will Battle It Out on Hairline Differences
April 2, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
April 2, 2026
·
3 min read
·
Annalee Armstrong
Layoffs
Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment
April 1, 2026
·
2 min read
·
Nick Paul Taylor
Business
11 Startups Selected for National Life Sciences Accelerator Program
April 1, 2026
·
2 min read
·
Angela Gabriel
